Stockreport

Sensorion Announces New Positive Clinical Data Across its Gene Therapy and Small Molecule Programs at the World Congress of Audiology in Paris [Yahoo! Finance]

COCHLEAR PLC UNSP/ADR  (CHEOY) 
PDF Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent [Read more]